Spravato® Therapy
Video Transcription
0:00
Feeling stuck when depression treatments haven’t worked?
0:03
You’re not alone.
0:04
Spravato offers a fresh,FDA approved option that works differently,helping many people feel relief faster compared to traditional antidepressants.
0:13
Spravato is a nasal spray that contains esketamine,a medicine that targets areas of the brain linked to mood.
0:19
It’s given in a LifeStance Health clinic,where caring professionals guide you every step of the way.
0:25
Spravato is for adults with treatment resistant depression,meaning two or more antidepressants haven’t worked.
0:31
Spravato is used with or without an oral antidepressant.
0:35
Here’s what to expect.
0:36
You’ll receive Spravato treatment in our clinic under the supervision of a specialty trained clinician,then relax in a comfortable space while we monitor you for about two hours.
0:46
Some people feel sleepy or a little detached for a short time,so you’ll need someone to drive you home and avoid driving until the next day.
0:54
In clinical studies,nearly 70% of participants saw their depression symptoms cut in half after starting Spravato.
1:02
Some may begin to notice improvement within three to seven days,sooner than traditional antidepressants that can take six to eight weeks.
1:10
See if Spravato might be right for you.
1:12
Take our quick depression questionnaire at lifestance.com/spravato.
1:18
Relief could begin now.
Rachel Dalthorp, MD, is the Executive Medical Director of Specialty Services at LifeStance Health, where she leads clinical programming and innovation in reproductive psychiatry, interventional psychiatry and the treatment of complex mental health needs. She is a board-certified psychiatrist through the American Board of Psychiatry and Neurology. She earned her medical degree from the University of Oklahoma College of Medicine and completed a four-year psychiatry residency at the University of Oklahoma Health Sciences Center, where developed expertise on the assessment and treatment of mood disorders related to the female reproductive cycle. Dr. Dalthorp also completed specialized training in the treatment of female sexual disorders and the use of psychedelic medications for depression. Dr. Dalthorp is the President of the Oklahoma Psychiatric Physicians Association and a Distinguished Fellow of the American Psychiatric Association. She is a former board member of the American Association of Ketamine Physicians and currently volunteers as an Assistant Professor of Psychiatry at the University of Oklahoma Health Sciences Center. Additionally, she is a founding member of the International Society of Reproductive Psychiatry, a nonprofit organization created to advocate for reproductive psychiatry education and improved access to services for patients. Dr. Dalthorp, her husband Bo, their three sons, two cats and golden retriever live in Norman, Oklahoma. She enjoys spending time with family and friends, going to estate sales with her mom Jane and upcycling vintage furniture and junk.
